WNT1-inducible signaling protein–1 mediates pulmonary fibrosis in mice and is upregulated in humans with idiopathic pulmonary fibrosis

Cited by (553)

Items 401–500 of 553

1. Circular RNAs and their roles in idiopathic pulmonary fibrosis
   Akshaya Mahalakshmi Surendran, Chaoqun Huang, Lin Liu · 2024 · Respiratory Research
2. Fibrosing interstitial lung diseases involve different pathogenic pathways with similar outcomes.
   Martina Vašáková, Venerino E. Poletti · 2015 · Sarcoidosis vasculitis and diffuse lung diseases
3. Targeting the myofibroblast to improve wound healing
   Boris Hinz · 2016 · Elsevier eBooks
4. Circulating MicroRNAs as Biomarkers for the Early Diagnosis of Lung Cancer and Its Differentiation from Tuberculosis
   Yeldar Ashirbekov, Nazgul Khamitova, Kantemir Satken, Arman Abaildayev, Ilya Pinsky, Askar Yeleussizov, Laura Yegenova, Anargul Kairanbayeva, Danara K. Kadirshe, Gulzhakhan Utegenova et al. · 2024 · Diagnostics
5. EGF Protects Epithelial Cells from Barrier Damage in Chronic Rhinosinusitis with Nasal Polyps
   L Chen, Quan Liu, Z.H. Liu, Han Li, Xiangguo Liu, Hongmeng Yu · 2022 · Journal of Inflammation Research
6. Bronchopulmonary dysplasia in adults: Exploring pathogenesis and phenotype
   Phillip S. Wozniak, Lara Makhoul, Mena M. Botros · 2023 · Pediatric Pulmonology
7. From Here to There, Progenitor Cells and Stem Cells Are Everywhere in Lung Vascular Remodeling
   Rebecca L. Heise, Patrick A. Link, László Farkas · 2016 · Frontiers in Pediatrics
8. Mechanisms of Fibrosis in IPF
   Nathan K. Sandbo · 2013 · Humana Press eBooks
9. Therapeutic molecular targets of SSc-ILD
   Yun Zhang, Jörg H. W. Distler · 2020 · Journal of Scleroderma and Related Disorders
10. Mechanical Ventilation with Moderate Tidal Volume Exacerbates Extrapulmonary Sepsis-Induced Lung Injury via IL33-WISP1 Signaling Pathway
    Shuai Liu, Meihong Deng, Pinhua Pan, Heth Roderick Turnquist, Bruce R. Pitt, Timothy R. Billiar, Liming Zhang · 2020 · Shock
11. Teatime: epigallocatechin gallate targets fibroblast–epithelial cell crosstalk to combat lung fibrosis
    Olivier Burgy, Mélanie Königshoff · 2024 · Journal of Clinical Investigation
12. Highly Calibrated Relationship Between Bleomycin Concentrations and Facets of the Active Phase Fibrosis in Classical Mouse Bleomycin Model
    Anil Hari Kadam, Jan E. Schnitzer · 2024 · International Journal of Molecular Sciences
13. Concomitant inhibition of hedgehog signalling and activation of retinoid receptors abolishes bleomycin‐induced lung fibrosis
    Ahmed Fawzy Eleraky, Gouda Kamel Helal, Mohamed Fathy Elshafie, Raed Shahat Ismail · 2021 · Clinical and Experimental Pharmacology and Physiology
14. Alveolar epithelial cell growth hormone releasing hormone receptor in alveolar epithelial inflammation
    Tengjiao Cui, Medhi Wangpaichitr, Andrew Victor Schally, Anthony J. Griswold, Irving Vidaurre, Wei Sha, Robert M. Jackson · 2023 · Experimental Lung Research
15. Dexmedetomidine alleviates pulmonary fibrosis through the ADORA2B-Mediated MAPK signaling pathway
    Xiaofan Lai, Yingying Lin, Shaojie Huang, Lvya Pu, Qihao Zeng, Zhongxing Wang, Wenqi Huang · 2023 · Respiratory Research
16. A murine model of acute lung injury identifies growth factors to promote tissue repair and their biomarkers
    Takeyuki Kurosawa, Shion Miyoshi, Soh Yamazaki, Takashi Nishina, Tetuo Mikami, Akira Oikawa, Sakae A. Homma, Hiroyasu Nakano · 2018 · Genes to Cells
17. NVP-BSK805, an Inhibitor of JAK2 Kinase, Significantly Enhances the Radiosensitivity of Esophageal Squamous Cell Carcinoma in vitro and in vivo
    Yuhui Hua, Weijia Wang, Xiaoli Zheng, Ling Yang, Hongjin Wu, Zhaoyang Hu, Ying Li, Jing Yue, Zhenzhen Jiang, Xiaoyan Zhang et al. · 2020 · Drug Design Development and Therapy
18. Regenerative Pathways and Emphysema: A New Paradigm?
    Anna P. Lam, Cara J. Gottardi, Rubin M. Tuder · 2011 · American Journal of Respiratory and Critical Care Medicine
19. β-Catenin and CCNs in lung epithelial repair
    William E. Lawson, Timothy S. Blackwell · 2013 · American Journal of Physiology-Lung Cellular and Molecular Physiology
20. Biomarkers in Systemic Sclerosis Associated Interstitial Lung Disease (SSc-ILD)
    Alice R Cole, Christopher Paul Denton · 2022 · Current Treatment Options in Rheumatology
21. WISP1 induces the expression of macrophage migration inhibitory factor in human lung fibroblasts through Src kinases and EGFR-activated signaling pathways
    Maria Elpida Christopoulou, Spyros S. Skandalis, Eleni Papakonstantinou, Daiana Stolz, Alexios J. Aletras · 2023 · American Journal of Physiology-Cell Physiology
22. Stretch-induced Expression of CYR61 Increases the Secretion of IL-8 in A549 Cells via the NF-κβ/lκβ Pathway
    Yan Zhang, Ping Guf, Shanglong Yao, Dong Yang, Yang Lv, Defang Ding · 2018 · Current Medical Science
23. WISP1 mediates lung injury following hepatic ischemia reperfusion dependent on TLR4 in mice
    Yao Tong, Zhuang Yu, Renlingzi Zhang, Xibing Ding, Zhixia Chen, Quan Li · 2018 · BMC Pulmonary Medicine
24. Role of platelet factor 4 in arteriovenous fistula maturation failure: What do we know so far?
    Yuxuan Xiao, Roberto I. Vázquez-Padrón, Laisel Martinez, Harold A. Singer, Daniel Woltmann, Loay H. Salman · 2022 · The Journal of Vascular Access
25. Basic fibroblast growth factor activates β-catenin/RhoA signaling in pulmonary fibroblasts with chronic obstructive pulmonary disease in rats
    Zhengxing Ge, Bo Li, Xun Zhou, Yi Yang, Jun Zhang · 2016 · Molecular and Cellular Biochemistry
26. WNT16 induces proliferation and osteogenic differentiation of human perivascular stem cells
    Carolyn Ann Meyers, Jia Shen, Amy Z. Lu, Aaron Watkins James · 2018 · Journal of Orthopaedics
27. Highly cited German research contributions to the fields of radiation oncology, biology, and physics: focus on collaboration and diversity
    Carsten Nieder · 2012 · Strahlentherapie und Onkologie
28. TGFβ1 generates a pro-fibrotic proteome in human lung parenchyma that is sensitive to pharmacological intervention
    Colleen B. Maxwell, Panayiota Stylianou, Hilary Marshall, Alfie J Hall, Paulene A. Quinn, Leong L. Ng, Donald J. L. Jones, Peter H. Bradding, Katy Morgan Roach · 2025 · European Journal of Pharmacology
29. Inhibition of SMYD2 attenuates paraquat-induced pulmonary fibrosis by inhibiting the epithelial-mesenchymal transition through the GLIPR2/ERK/p38 axis
    Zheng Zhao, Xue Yang · 2024 · Pesticide Biochemistry and Physiology
30. WISP-1 Regulates Cardiac Fibrosis by Promoting Cardiac Fibroblasts’ Activation and Collagen Processing
    Ze Li, Helen J Williams, Molly L. Jackson, Jason Lee Johnson, Sarah J. George · 2024 · Cells
31. New targets in idiopathic pulmonary fibrosis: from inflammation and immunity to remodeling and repair
    Antoine Froidure, Audrey Joannes, Arnaud Mailleux, Bruno Crestani · 2016 · Expert Opinion on Orphan Drugs
32. The Effects of WISP1 Polymorphisms on the Prognosis of Lung Cancer Patients with Platinum-Based Chemotherapy
    Jia He, Zhan Wang, Ying Wang, Ting Zou, Xiangping Li, Lei Cao, Juan Chen · 2021 · Pharmacogenomics and Personalized Medicine
33. Cyclophosphamide as disease-modifying therapy for scleroderma: pros and cons
    Cecilia Beatrice Chighizola, Voon Hong Ong, Christopher Paul Denton · 2011 · International Journal of Clinical Rheumatology
34. Live and Let Die: Targeting Alveolar Epithelial Cell Proliferation in Pulmonary Fibrosis
    Mélanie Königshoff, Philippe Bonniaud · 2014 · American Journal of Respiratory and Critical Care Medicine
35. Fueling the fire: metabolic dysfunction and senescence as drivers of lung aging and disease
    Corrine R. Kliment, Aditi U. Gurkar, Nayra Cárdenes, Richard Paul Ramonell, Toren Finkel, Mélanie Königshoff · 2026 · Physiological Reviews
36. Epithelial stem cells at the intersection of tissue regeneration and pulmonary fibrosis
    Manuela Platé, Yoshihiko Kobayashi, Rachel Clare Chambers, Purushothama Rao Tata · 2021 · European Respiratory Society eBooks
37. Organophosphate flame retardant triphenyl phosphate (TPhP) induced colonic fibrosis by bringing about epithelial-mesenchymal transition
    Chunyan Peng, Mo Wang, Chang Zheng, Xiaoqi Zhang, Yabing Chen, Lei Wang · 2025 · Ecotoxicology and Environmental Safety
38. Non-canonical Wnt signaling promotes epithelial fluidization in the repairing airway
    Daniel Jun-Kit Hu, Xiaoyu Tracy Cai, Jesse Simons, Jina Yun, Justin Elstrott, Heinrich Jasper · 2025 · Nature Communications
39. Profibrosing Effect of Angiotensin Converting Enzyme Inhibitors in Human Lung Fibroblasts
    Gabriela Díaz-Piña, Eduardo Montes, Marco Checa, Carina Becerril, Carolina García de Alba, Anita Vega, Ignacio Páramo, Rosa María Ordóñez‐Razo, Vı́ctor Ruiz · 2015 · Lung
40. Bleomycin induced apical-basal polarity loss in alveolar epithelial cell contributes to experimental pulmonary fibrosis
    Yuzhi Lu, Xin‐Liang He, Fei Liu, Peipei Cheng, Limei Liang, Meng Wang, Shuai-Jun Chen, Yi Huang, Yu Fan, Jian‐Bao Xin et al. · 2020 · Experimental Cell Research
41. Relationship of Wnt pathway activity and organ involvement in scleroderma types
    Ayşe Koçak, Duygu Harmancı, Gül Güner, Merih Bırlık · 2020 · International Journal of Rheumatic Diseases
42. A broad look into the future of systemic sclerosis
    Gabriela Riemekasten, Jörg H. W. Distler · 2022 · Therapeutic Advances in Musculoskeletal Disease
43. The Exciting Future for Scleroderma
    Jörg H. W. Distler, Gabriela Riemekasten, Christopher Paul Denton · 2023 · Rheumatic Disease Clinics of North America
44. Wnt-induced secreted proteins-1 play an important role in paraquat-induced pulmonary fibrosis
    Lanrong Li, Shengnan Lv, Xin Li, Jingyan Liu · 2022 · BMC Pharmacology and Toxicology
45. Acute Respiratory Distress Syndrome
    Rachel L. Zemans · 2017 · Elsevier eBooks
46. A two-pronged weapon in the fight against fibrosis. Focus on “Inhibition of Wnt/β-catenin signaling promotes epithelial differentiation of mesenchymal stem cells and repairs bleomycin-induced lung injury”
    Rennolds S. Ostrom · 2014 · American Journal of Physiology-Cell Physiology
47. Listen to the WNT; It Talks: WNT7A Drives Epithelial–Mesenchymal Cross-Talk within the Fibrotic Niche in Idiopathic Pulmonary Fibrosis
    Mélanie Königshoff, Oliver Eickelberg · 2022 · American Journal of Respiratory Cell and Molecular Biology
48. Plasma-Based Scaffold Containing Bone-Marrow Mononuclear Cells Promotes Wound Healing in a Mouse Model of Pressure Injury
    María Álvarez‐Viejo, Luis Romero-Rosal, Marcos Pérez‐Basterrechea, Jose Maria Garcia Gala, Pablo Hernando-Rodriguez, Jesus Marana-Gonzalez, Miriam Rubiera-Valdés, Blanca Vivanco–Allende, Angeles Fernández‐Rodríguez, Eva Martinez Revuelta et al. · 2024 · Cell Transplantation
49. Repurposing of the small-molecule adrenoreceptor-inhibitor carvedilol for treatment of the fibrotic lung
    Maria Jordan, Kevin Schmidt, Maximilian Fuchs, Annette Just, Angelika Pfanne, Lena Willmer, Lavinia Neubert, Christopher Werlein, Patrick Zardo, Andreas Pich et al. · 2025 · Frontiers in Pharmacology
50. Cellular mechanisms in the pathogenesis of interstitial lung diseases
    Priyanka Singh, Saba Naaz Ali, Sufian Zaheer, Mukul Pratap Singh · 2023 · Pathology - Research and Practice
51. Wnt Pathway Activation in Long Term Remnant Rat Model
    Elisenda Bañón-Maneus, Jordi Rovira, María José Ramírez-Bajo, Daniel Moya-Rull, Natalia Hierro-Garcia, Shinji Takenaka, Fritz Diekmann, Oliver Eickelberg, Mélanie Königshoff, Josep Maria Campistol · 2014 · BioMed Research International
52. Stem cell therapy for idiopathic pulmonary fibrosis: How far are we from the bench to the bedside?
    Zheng Wang, Xiaoju Zhang, Yi Kang, Yanli Zeng, Hongmei Liu, Xiaoqian Chen, Lijun Ma · 2013 · Journal of Biomedical Science and Engineering
53. Involvement of multiple CCN family members in platelets that support regeneration of joint tissues
    Chikako Hara, Satoshi Kubota, Takashi Nishida, Miki Hiasa, Takako Hattori, Eriko Aoyama, Yoshinori Moriyama, Hiroshi Kamioka, Masaharu Takigawa · 2016 · Modern Rheumatology
54. MicroRNAs in Idiopathic Pulmonary Fibrosis
    Kusum V. Pandit, Naftali Kaminski · 2016 · Elsevier eBooks
55. Pulmonary Hypertension due to Fibrotic Lung Disease: Hidden Value in a Neutral Trial
    Steven D. Nathan, Roberto G. Carbone · 2014 · American Journal of Respiratory and Critical Care Medicine
56. Correction: HMGB1 Accelerates Alveolar Epithelial Repair via an IL-1β- and αvβ6 Integrin-dependent Activation of TGF-β1
    Jean‐François Pittet, Hidefumi Koh, Xiaohui Fang, Karen E. Iles, Sarah C. Christiaans, Naseem Anjun, Brant M. Wagener, Dae Won Park, Jaroslaw W. Zmijewski, Michael A. Matthay et al. · 2013 · PLoS ONE
57. Engineered Extracellular Vesicles from Human Skin Cells Induce Pro‐β‐Cell Conversions in Pancreatic Ductal Cells
    Lilibeth Ortega‐Pineda, Maria Angelica Rincon‐Benavides, Tatiana Z. Cuellar‐Gaviria, Mia Kordowski, Elizabeth Guilfoyle, Amrita Lakshmi Anaparthi, Luke R. Lemmerman, William R. Lawrence, Jill L. Buss, Binbin Deng et al. · 2023 · Advanced NanoBiomed Research
58. A phase 1 study evaluating the safety, tolerability, and pharmacokinetics of the porcupine inhibitor, AZD5055
    Xiaohong Zhou, Susanne Prothon, L Engin, Nicola Ferrari, Kebria Hezaveh, Zhi Liu, Szilárd Nemes, Joachim Almquist, Michael L. Williams, Olami Sobande et al. · 2025 · iScience
59. Secreted frizzled-related protein 3 alleviated cardiac remodeling induced by angiotensin II via inhibiting oxidative stress and apoptosis in mice
    Yang Gu, Ying Ding, Xin Zhang, Yong Li, Zhenglu Shang · 2022 · European Journal of Pharmacology
60. Engraftment of wild-type alveolar type II epithelial cells in surfactant protein C deficient mice
    Camilla Predella, Lauren M. Lapsley, Keyue Ni, Tania Ahalya Thimraj, Hsiao‐Yun Liu, John W. Murray, Joshua E. Motelow, Hans‐Willem Snoeck, Stephan W. Glasser, Anjali Saqi et al. · 2026 · npj Regenerative Medicine
61. Innovations thérapeutiques de la fibrose pulmonaire idiopathique
    Y. Uzunhan, Hilario Nunès, Thomas Gille, Camille Bron, Carole Planès, Dominique Valeyre · 2011 · La Presse Médicale
62. Injury and Repair
    Rachel L. Zemans, Gregory Paul Downey · 2015 · Elsevier eBooks
63. Macrophages and Fibrosis Resolution. Harnessing Wnt/β-Catenin Signaling as the Way and the Means
    Elizabeth F. Redente · 2017 · American Journal of Respiratory Cell and Molecular Biology
64. Circulating microRNAs demonstrate limited diagnostic potential for diabetic retinopathy in the population of Kazakhstan
    Aizhan Magazova, Yeldar Ashirbekov, Arman Abaildayev, Kantemir Satken, Gulzhakhan Utegenova, BELKOZHAYEV AYAZ MARATOVICH, Altynay Balmukhanova, Zaure Dzhumataeva, Беисова Айнагуль Айдарбековна, Iryna V. Shargorodska et al. · 2025 · PeerJ
65. Altered Expressions of IL-15, IFNG, and HPRT1 Genes in the Thin Endometria of Patients with Reproductive Disorders: A Prospective Comparative Study
    Аlmagul Kurmanova, Yeldar Ashirbekov, Gaukhar Kurmanova, Н.М. Мамедалиева, Gaini Anartayeva, Gaukhar Moshkalova, Damilya Salimbayeva, Aidana Tulesheva, Zhamilya Zhankina · 2024 · Journal of Clinical Medicine
66. Effect of WISP1 on paraquat-induced EMT
    Jingyan Liu, Shengnan Lv, Wanling Ma, Dong Yang, Xuchang Zhang · 2023 · Toxicology in Vitro
67. Genetic Underpinnings of Pulmonary Fibrosis: An Overview
    Sushweta Mahalanobish, Sumit Ghosh, Parames Chandra Sil · 2024 · Cardiovascular & Hematological Agents in Medicinal Chemistry
68. WISP-1 overexpression upregulates cell proliferation in human salivary gland carcinomas via regulating MMP-2 expression
    Fujun Li, Xinjuan Wang, Xiaoli Zhou · 2016 · OncoTargets and Therapy
69. Calcium gluconate alleviates the toxic effect of hydrofluoric acid on human dermal fibroblasts through the Wnt/β‑catenin pathway
    Jinxia Peng, Rui R Liu, Ling Peng, Hongtao Jia · 2018 · Oncology Letters
70. The main pathogenetic mechanisms of pneumosclerotic changes in the lungs of coal industry workers
    О. И. Бондарев, Maria S. Bugaeva, Anastasiya S. Kazitskaya · 2022 · Russian Journal of Occupational Health and Industrial Ecology
71. Plakoglobin expression in fibroblasts and its role in idiopathic pulmonary fibrosis
    Stephanie A. Matthes, Thomas J. LaRouere, Jeffrey Craig Horowitz, Eric S. White · 2015 · BMC Pulmonary Medicine
72. Emerging Therapeutic Targets and Therapies in Idiopathic Pulmonary Fibrosis
    Vineela Parvathaneni, Snehal K. Shukla, Vivek Gupta · 2018 · Molecular and translational medicine
73. microRNA Expression Profile of Purified Alveolar Epithelial Type II Cells
    Stefan Dehmel, Katharina J. Weiß, Natalia El-Merhie, Jens Callegari, Birte Konrad, Kathrin Mutze, Oliver Eickelberg, Mélanie Königshoff, Susanne Krauss‐Etschmann · 2022 · Genes
74. Could N-acetylcysteine slow progression of idiopathic pulmonary fibrosis by inhibiting EMT?
    Paul J. Wolters · 2009 · American Journal of Physiology-Lung Cellular and Molecular Physiology
75. Defining the Cell Types That Drive Idiopathic Pulmonary Fibrosis Using Single-Cell RNA Sequencing
    Joanna M. Poczobutt, Oliver Eickelberg · 2019 · American Journal of Respiratory and Critical Care Medicine
76. Altered Expression of C4BPA and CXCL1 Genes in the Endometrium of Patients with Recurrent Implantation Failure after In Vitro Fertilization and Thin Endometrium
    Gaukhar Kurmanova, Yeldar Ashirbekov, Аlmagul Kurmanova, Н.М. Мамедалиева, Gaukhar Moshkalova, Gaini Anartayeva, Damilya Salimbayeva, Aidana Tulesheva · 2024 · Diagnostics
77. The role of tetraspanins in organ fibrosis: mechanisms and therapeutic perspectives
    Shengbiao Li, Mi Li, Yi Zhang, Ji Chen, Jiawei Li, Shanlin Fu, Jingyan Yi, Rong Li, Gan Qiao, Yu Yang et al. · 2025 · Journal of Translational Medicine
78. Cannabis and Cannabidiol: Pioneering Treatment for the Nervous System with Alzheimer's Disease and Peripheral Organ Involvement with Nonalcoholic Fatty Liver Disease (NAFLD)
    Kenneth Maiese · 2025 · Current Neurovascular Research
79. Aging and Intestinal Fibrosis: Mechanisms, Implications, and Therapeutic Strategies
    Yujie Shi, Han Zheng, Xiaxin Zhu, Jianyu Lv, Mi Zhou, Shuo Zhang · 2025 · Clinical Interventions in Aging
80. Human lung stem cells: Oh, the places you'll go!
    Mélanie Königshoff, Johannes Schwarz, Oliver Eickelberg · 2011 · EMBO Molecular Medicine
81. Is Lung Disease a Risk Factor for Sudden Cardiac Death? A Comparative Case–Control Histopathological Study
    Ioana Radu, Anca Otilia Farcas, Septimiu Voidăzan, Carmen Corina Radu, Klara Brînzaniuc · 2025 · Diseases
82. Aspects of histogenesis of the coniotic process in workers of the main professions of the coal industry
    О. И. Бондарев, Maria S. Bugaeva, Anastasiya S. Kazitskaya, Егор Сергеевич Филимонов, S. L. Kan · 2019 · Russian Journal of Occupational Health and Industrial Ecology
83. Involvement of the TGF-β pathway in epithelialmesenchymal transition promoted by the pulmonary microenvironment in Mycoplasma pneumoniae pneumonia
    Lu Fan, Huixia Wang, Nuo Xu, Yun Guo, Ling Li · 2024 · Archives of Biological Sciences
84. Evaluation of the protective effect of Compound Kushen Injection against radiation‑induced lung injury in mice
    Ting Xu, Sharmistha Chakraborty, Daoyan Wei, Megan Tran, Robyn Rhea, Bo Wei, Phuong Nguyen, Mihai Gagea, Xiaoxue Xie, Lirong Wu et al. · 2025 · Molecular Medicine Reports
85. An Assessment of Epithelial and Mesenchymal Phenotypes in Experimental and Clinical Pulmonary Fibrosis
    Rebecca Dunmore, Alan M. Carruthers, Matthew J. Bell, Huilan Zhang, Cory M. Hogaboam, Xueyang Peng, Erica L. Herzog, Darryl A. Knight, Fernando J. Martínez, Matthew A. Sleeman et al. · 2012 · ISRN Pulmonology
86. Evolving Genomics of Pulmonary Fibrosis
    Jose D. Herazo‐Maya, Naftali Kaminski · 2013 · Humana Press eBooks
87. “A SMALL LEAK WILL SINK A GREAT SHIP”: HYPOXIA-INDUCIBLE FACTOR AND GROUP III PULMONARY HYPERTENSION
    Andrew J. Bryant, Edward W. Scott · 2016 · Receptors & Clinical Investigation
88. Fibrosis and Immune Dysregulation in Systemic Sclerosis
    Yahya Argobi, Gideon Piers Smith · 2018 · Molecular and translational medicine
89. Pulmonary Fibrosis
    Lynne A. Murray, Robert Homer, Mridu Gulati, Erica L. Herzog · 2014 · Elsevier eBooks
90. Reply to Fujino et al
    Andreas Christian Hocke, Johanna Berg, Anne Becher, Jessica Knepper, Frederick Klauschen, Mario Tönnies, Torsten Thomas Bauer, Paul Schneider, Jens Neudecker, Jens Carsten Rückert et al. · 2012 · The Journal of Infectious Diseases
91. Is “CTGF” Still a Viable Anti-Fibrotic Target?
    Andrew Leask · 2025 · Fibrosis
92. MSCs attenuate airway remodeling in HDM-induced asthma by inhibiting the Timp1-Wnt2b axis
    Kai Yu, Xinyu Feng, Rong Zhang, Jian‐Gao Fan, Jiaying Yuan, Yan Shang, Jiayi Zhao · 2025 · Acta Biochimica et Biophysica Sinica
93. Basement membrane remodeling with fibroblast activation and cystatin C aggregation in cerebral vessels of hereditary cystatin C amyloid angiopathy
    Ásbjörg Ósk Snorradóttir, Hjalti Karl Hafsteinsson, Klara Hansdottir, Sævar Ingþórsson, Sigurdur Runar Gudmundsson, Angelos Skodras, Helgi J. Ísaksson, Hakon H. Hakonarson · 2026 · Acta Neuropathologica Communications
94. Will o’ the WISP1: A novel mediator of Ang-II induced cardiomyocyte hypertrophy
    Eva Denise Martin, Michael S. Marber · 2011 · Journal of Molecular and Cellular Cardiology
95. Grundlagen, Epidemiologie und Pathogenese der idiopathischen Lungenfibrose
    Antje Prasse, Joachim Müller–Quernheim · 2013 · Der Pneumologe
96. Developments into understanding the pathogenesis of systemic sclerosis
    Nicolas Hunzelmann · 2013 · Expert Review of Dermatology
97. Role of WNT1-inducible-signaling pathway protein 1 in etoposide resistance in lung adenocarcinoma A549 cells.
    Yunhua Xu, Shun Lü · 2015 · PubMed
98. Regenerative Medicine and the Hope for a Cure
    Mareike Lehmann, Mélanie Königshoff · 2021 · Clinics in Chest Medicine
99. Evolving Genomics of Pulmonary Fibrosis
    Gabriel Lara Ibarra, Jose D. Herazo‐Maya, Naftali Kaminski · 2018 · Respiratory medicine
100. Epigenetics and Fibrosis
     Bin Liu, Xin Sheng Wang, Huimin Chen, Qianjin Lu, M. Eric Gershwin, Patrick S.C. Leung · 2015 · Elsevier eBooks